Pharvaris N.V. (PHVS) Earnings Call Transcripts

16 earnings calls from March 2021 to September 8, 2026

NasdaqGS US Health Care Pharmaceuticals

About Pharvaris N.V.

Pharvaris N.V. (PHVS) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning March 11, 2021 to September 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 16 Pharvaris N.V. earnings call transcripts on record, spanning March 11, 2021 to September 8, 2026. Based on this history, Pharvaris N.V. reports semi-annually. The most recent call on file is dated September 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
PHVS
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
16
First call
March 11, 2021
Most recent
September 8, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Sep 8, 2026 Read transcript
Company Conference Presentations May 13, 2026 Read transcript
Special Calls Dec 3, 2025 Read transcript
Company Conference Presentations Sep 10, 2025 Read transcript
Company Conference Presentations Sep 4, 2025 Read transcript
Company Conference Presentations Sep 3, 2025 Read transcript
Special Calls Jun 4, 2025 Read transcript
Company Conference Presentations May 14, 2025 Read transcript
Company Conference Presentations Mar 10, 2025 Read transcript
Company Conference Presentations Feb 12, 2025 Read transcript
Company Conference Presentations Jan 16, 2025 Read transcript
Company Conference Presentations May 10, 2023 Read transcript
Special Calls Dec 8, 2022 Read transcript
Company Conference Presentations Apr 11, 2022 Read transcript
Company Conference Presentations Feb 16, 2022 Read transcript
Company Conference Presentations Mar 11, 2021 Read transcript